酚妥拉明与低分子肝素联合治疗肺心病急性加重期的疗效观察

摘要

Objective To analyzed the clinical effect of low molecular heparin combine with phentolamine in treatment of acute exacerbation of pulmonary heart disease. Methods 69 cases of pulmonary heart disease in acute exacerbation period were randomly divided into two groups,compared two groups of patients with therapeutic effect. Results The total effective rate of the treatment group was signiifcantly higher than that of the control group, the whole blood viscosity, plasma viscosity, erythrocyte aggregation index improved signiifcantly than the control group, PaO2 was signiifcantly higher than the control group, PaCO2 was significantly lower than the control group, P<0.05. Conclusion Phentolamine and low molecular weight heparin combination therapy pulmonary heart disease acute exacerbation has signiifcant effect.%目的：分析酚妥拉明与低分子肝素联合治疗肺心病急性加重期的疗效。方法将69例肺心病急性加重期患者随机分为两组，对比两组患者治疗效果。结果治疗组治疗总有效率较对照组提高，治疗后全血粘度、血浆粘度、红细胞聚集指数改善程度优于对照组，PaO2较对照组提高，PaCO2较对照组降低，P＜0.05。结论酚妥拉明与低分子肝素联合治疗肺心病急性加重期取得显著效果，显著改善患者心肺功能。